Search research articles
Contact Us
Filters
Showing results (201-210 of 215) with videos related to
Page
of 22
Sort By:
NPJ Vaccines
|
May 3, 2026
Searching for immune correlates in Lassa vaccine development - workshop report
Trevor Brasel, Polina Brangel, Ifedayo Adetifa, et al.
Archives of Virology
|
September 25, 2012
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae
Jens H Kuhn, Yiming Bao, Sina Bavari, et al.
Ebiomedicine
|
March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials
Christopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Cell Reports
|
April 4, 2025
A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein
Sharon L Schendel, Xiaoying Yu, Peter J Halfmann, et al.
Scientific Reports
|
April 14, 2018
Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
Matthew L Boisen, Jessica N Hartnett, Jeffrey G Shaffer, et al.
Scientific Reports
|
September 30, 2020
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
Megan L Heinrich, Matthew L Boisen, Diana K S Nelson, et al.
Cell
|
August 11, 2018
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
Erica Ollmann Saphire, Sharon L Schendel, Marnie L Fusco, et al.
Archives of Virology
|
January 30, 2013
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae
Jens H Kuhn, Yiming Bao, Sina Bavari, et al.
Nature Communications
|
May 11, 2016
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
James E Robinson, Kathryn M Hastie, Robert W Cross, et al.
Plos Neglected Tropical Diseases
|
March 22, 2014
Lassa fever in post-conflict sierra leone
Jeffrey G Shaffer, Donald S Grant, John S Schieffelin, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 215) with videos related to
Sort By:
Page
of 22
NPJ Vaccines
|
May 3, 2026
Searching for immune correlates in Lassa vaccine development - workshop report
Trevor Brasel, Polina Brangel, Ifedayo Adetifa, et al.
Archives of Virology
|
September 25, 2012
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae
Jens H Kuhn, Yiming Bao, Sina Bavari, et al.
Ebiomedicine
|
March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials
Christopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Cell Reports
|
April 4, 2025
A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein
Sharon L Schendel, Xiaoying Yu, Peter J Halfmann, et al.
Scientific Reports
|
April 14, 2018
Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
Matthew L Boisen, Jessica N Hartnett, Jeffrey G Shaffer, et al.
Scientific Reports
|
September 30, 2020
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
Megan L Heinrich, Matthew L Boisen, Diana K S Nelson, et al.
Cell
|
August 11, 2018
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
Erica Ollmann Saphire, Sharon L Schendel, Marnie L Fusco, et al.
Archives of Virology
|
January 30, 2013
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae
Jens H Kuhn, Yiming Bao, Sina Bavari, et al.
Nature Communications
|
May 11, 2016
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
James E Robinson, Kathryn M Hastie, Robert W Cross, et al.
Plos Neglected Tropical Diseases
|
March 22, 2014
Lassa fever in post-conflict sierra leone
Jeffrey G Shaffer, Donald S Grant, John S Schieffelin, et al.
Page
of 22